Goodwin

Partner

John W. Jones is a partner in the Private Equity group at Goodwin, a Co-Leader of the firm’s Healthcare Private Equity practice, and Chair of the Healthcare Regulatory and Compliance practice. He joined the firm in 2023.

John focuses his practice on healthcare private equity and strategic M&A and complex federal and state healthcare regulatory matters. He represents financial sponsors and strategics on a wide range of corporate, M&A, regulatory, structure, governance and compliance matters. Clients with a stake in the healthcare industry rely on John to navigate their most important deals and complex issues. Recognized for his significant expertise and 20+ years of experience in the healthcare M&A industry, John was named Healthcare M&A lawyer of the year by America M&A Atlas Awards in 2019.

John’s clients include private equity firms, strategics (including public and private healthcare companies), providers and suppliers, wholesalers and distributors, pharmaceutical companies, group purchasing organizations and cooperatives, post-acute and alternate site providers (including pharmacies, rehab, home health and hospice), physician groups and physician practice management companies in all healthcare subsectors, senior living organizations, national health systems, academic medical centers, faculty practice plans, IT companies and vendors. He advises clients on corporate planning, finance, and structuring of transactions, including mergers, acquisitions (including platform add-ons and roll-up acquisitions) and dispositions, joint ventures, restructuring and reorganizations, collaborations, partnering arrangements, and strategic alliances.

John counsels healthcare companies throughout the medical and pharmaceutical supply chain on transactions as well advises clients on complex audits and white-collar investigations. John has handled transactions ranging in size from several million to more than $3 billion, and his experience handling white collar matters — including audits and investigations — helps clients to anticipate and minimize deal risk. He has significant experience handling regulatory issues arising under fraud and abuse laws (including the federal Anti-Kickback Statute), Stark, civil monetary penalties law, False Claims Act, healthcare fraud statutes, HIPAA and privacy and security, reimbursement, state laws, including CPOM, fee splitting, licensing, credentialing and state Board issues and mini anti-referral and anti-fraud and abuse laws and other laws that impact healthcare clients and M&A transactions.

John also handles the full range of traditional healthcare and managed care and payor issues such as hospital-physician relations, nonprofit and reserved power issues, attorney general and orphan’s court issues and procedures, certificates of need and licensure, patient rights issues, including care access and delivery issues and reimbursement and payor issues. Providers and suppliers rely on John to interface with some of the top managed care companies and PBMs on some of the most transformative and challenging payment issues including, value-based care and risk share arrangements. John helped establish the first national Medicare Part D PSAO and regularly negotiates agreements with the top five PBMs and payors in the country as well as handling PBM audits and disputes. John is also recognized as one of the nation’s legal leaders with respect to payment and regulatory issues impacting alternate site and at home care providers, group purchasing organizations, and supply chain participants.

JD 1997 The Pennsylvania State University Dickinson School of Law; MSW 1997 University of Pennsylvania; BA 1993 University of Delaware (cum laude)